ArticleACS medicinal chemistry letters2020

Discovery of a Selective, Covalent IRAK1 Inhibitor with Antiproliferative Activity in MYD88 Mutated B-Cell Lymphoma.

John M Hatcher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.